Accession Number: | 0001209191-20-010322 |
Date: | 2020-02-13 |
Issuer: | MEDNAX, INC. (MD) |
Original Submission Date: |
WALDEMAR, MD CARLO A
1301 CONCORD TERRACE
SUNRISE, FL 33323
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2020-02-13 | A | 4,717 | a | $0.00 | 31,802 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|
ID | footnote |
---|---|
f1 | restricted shares granted pursuant to issuer's amended and restated 2008 incentive compensation plan, in connection with annual equity award. shares will vest in three equal installments on march 1, 2021, march 1, 2022 and march 1, 2023. |